Clinical Study Results
Research Sponsor: AstraZeneca
Drug Studied: BGF MDI and GFF MDI
Study Title: A study to find out how BGF MDI and GFF MDI affect the
lungs of participants with COPD
Thank you!
Thank you for taking part in the clinical study for the study treatments BGF MDI
and GFF MDI. These treatments are also called budesonide glycopyrronium
formoterol fumarate metered dose inhaler and glycopyrronium formoterol fumarate
metered dose inhaler.
You and all of the participants helped researchers learn more about BGF MDI and
GFF MDI to help people who have chronic obstructive pulmonary disease, also
called COPD.
AstraZeneca sponsored this study and believes it is important to share the results
of the study with you and the public. An independent non-profit organization called
CISCRP helped prepare this summary of the study results for you. We hope it
helps you understand and feel proud of your important role in medical research.
If you participated in the study and have questions about the results, please speak
with the study doctor or staff at your study site.
1